浏览全部资源
扫码关注微信
- Journal Information
- Archive
- Submission
- For Reviewers
- Statement and Policies
Simultaneous determination of bepotastine and hydroxychloroquine concentrations in human breast milk by LC-MS/MS
- ZHONGGUO YAOFANG Vol. 35, Issue 11, Pages: 1363-1368(2024)
- 作者机构：
1.杭州市第一人民医院药学部，杭州 310006
2.浙江省食品药品检验研究院国家药品监督管理局仿制药评价关键技术重点实验室，杭州 310052
- 作者简介：
- 基金信息：
DOI：10.6039/j.issn.1001-0408.2024.11.14
CLC： R969.1Published：15 June 2024，
Received：07 November 2023，
Revised：20 April 2024，
扫 描 看 全 文
白梦如,申潜,马志媛等.LC-MS/MS法同时测定人乳汁中贝他斯汀和羟氯喹的浓度 Δ[J].中国药房,2024,35(11):1363-1368.
BAI Mengru,SHEN Qian,MA Zhiyuan,et al.Simultaneous determination of bepotastine and hydroxychloroquine concentrations in human breast milk by LC-MS/MS[J].ZHONGGUO YAOFANG,2024,35(11):1363-1368.
白梦如,申潜,马志媛等.LC-MS/MS法同时测定人乳汁中贝他斯汀和羟氯喹的浓度 Δ[J].中国药房,2024,35(11):1363-1368. DOI： 10.6039/j.issn.1001-0408.2024.11.14.
BAI Mengru,SHEN Qian,MA Zhiyuan,et al.Simultaneous determination of bepotastine and hydroxychloroquine concentrations in human breast milk by LC-MS/MS[J].ZHONGGUO YAOFANG,2024,35(11):1363-1368. DOI： 10.6039/j.issn.1001-0408.2024.11.14.
摘要
目的
2
建立同时测定人乳汁中贝他斯汀和羟氯喹浓度的液相色谱-质谱联用（LC-MS/MS）方法并应用于临床。
方法
2
向50 μL乳汁样品中加入200 μL含内标（100 ng/mL氯喹）的甲醇，涡旋沉淀蛋白后离心取上清液进样分析。色谱柱为Waters ACQUITY UPLC HSS T3柱，流动相为0.1%甲酸-10 mmol/L乙酸铵溶液（A相）和甲醇（B相）（梯度洗脱），流速为0.35 mL/min，进样量为2 μL，分析时间为4 min。采用电喷雾离子源，正离子多反应监测模式扫描，定量分析离子对分别为
m
/
z
388.9→201.9（贝他斯汀）、
m
/
z
336.3→247.1（羟氯喹）和
m
/
z
320.2→247.2（氯喹）。对所建LC-MS/MS法进行方法学考察，并用于检测1例哺乳期患者乳汁中的药物浓度。
结果
2
贝他斯汀在2～200 ng/mL
（
r
＝0.999）、羟氯喹在50～1 000 ng/mL（
r
＝0.998）范围内线性关系良好。贝他斯汀和羟氯喹质控样本的批内、批间精密度均小于15%，准确度、提取回收率、基质效应和稳定性均符合生物样品定量分析方法验证要求。哺乳期患者乳汁中的药物浓度检测结果显示，该患者服药2 h和14 h后乳汁中贝他斯汀的浓度分别为34.95、5.72 ng/mL，羟氯喹分别为211.92、104.18 ng/mL，推算出相对婴儿剂量分别为1.83%、0.56%。
结论
2
该方法操作简便、快速、灵敏度高，适用于人乳汁中贝他斯汀和羟氯喹浓度的同时测定，可为临床哺乳期的安全用药提供参考。
Abstract
OBJECTIVE
2
To establish a liquid chromatography-tandem mass spectrometry （LC-MS/MS） method for the simultaneous determination of bepotastine and hydroxychloroquine concentrations in human breast milk and apply it in clinical practice.
METHODS
2
The milk samples （50 μL） were precipitated with 200 μL methanol containing the internal standard （100 ng/mL chloroquine）， and the supernatant was taken for analysis after vortexing and centrifugation. The separation was performed on a Waters ACQUITY UPLC HSS T3 column with mobile phase consisted of 0.1% formic acid-10 mmol/L ammonium acetate solution （phase A） and methanol （phase B） at gradient elution of 0.35 mL/min. The injection volume was 2 μL， and the analysis time was 4 min. The detection of the analytes was performed by electrospray ionization in positive mode by multiple reaction monitoring with the transition of
m
/
z
388.9→201.9 （bepotastine），
m
/
z
336.3→247.1 （hydroxychloroquine）， and
m
/
z
320.2→247.2 （chloroquine）. The established LC-MS/MS method was researched in methodology and used to determine the drug concentrations in the breast milk of 1 case of lactating patient.
RESULTS
2
The linear range of bepotastine was 2-200 ng/mL
（
r
＝0.999）， and hydroxychloroquine was 50-1 000 ng/mL
（
r
＝0.998）. The intra-assay and inter-assay precisions were both ≤15%， and the accuracy， extraction recovery， matrix effect， and stability all met the acceptance criteria for bioanalytical method validation. The concentration result of bepotastine and hydroxychloroquine in the breast milk of the lactating patient showed， after 2 h and 14 h， the concentrations of bepotastine in the breast milk of the patient were 34.95 ng/mL and 5.72 ng/mL； those of hydroxychloroquine were 211.92 ng/mL and 104.18 ng/mL
， respectively. The relative infant doses were 1.83% and 0.56%， respectively.
CONCLUSIONS
2
The established method is simple， rapid， and sensitive. It is suitable for simultaneous determination of bepotastine and hydroxychloroquine concentrations in human milk and can provide reference for safe drug use during lactation.
关键词
贝他斯汀羟氯喹乳汁哺乳期药物浓度液相色谱-质谱联用技术
Keywords
hydroxychloroquinebreast milklactationdrug concentrationLC-MS/MS
references
吴文格，何秋，詹衡，等. 苯磺贝他斯汀的合成工艺优化[J]. 中国药物化学杂志，2023，33（5）：352-355.
WU W G，HE Q，ZHAN H，et al. Improved synthetic process of bepotastine besilate[J]. Chin J Med Chem，2023，33（5）：352-355.
WILLIAMS J I，GOW J A，KLIER S M，et al. Non-clinical pharmacology，pharmacokinetics，and safety fin- dings for the antihistamine bepotastine besilate[J]. Curr Med Res Opin，2010，26（10）：2329-2338.
邱洋洋，余红. 羟氯喹在皮肤疾病中应用及安全性研究进展[J]. 医学综述，2019，25（19）：3870-3874，3879.
QIU Y Y，YU H. Application and safety of hydroxychloroquine in dermatoses[J]. Med Recapitul，2019，25（19）：3870-3874，3879.
陈鸿裕，刘晨美，曾抗，等. 羟氯喹在皮肤科应用的系统回顾[J]. 皮肤科学通报，2021，38（4）：350-356，6.
CHEN H Y，LIU C M，ZENG K，et al. Systematic review：application of hydroxychloroquine in dermatology[J]. Dermatol Bull，2021，38（4）：350-356，6.
MOTTA M，TINCANI A，FADEN D，et al. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation[J]. J Perinatol，2005，25（2）：86-89.
PENG W X，LIU R J，ZHANG L J，et al. Breast milk concentration of hydroxychloroquine in Chinese lactating women with connective tissue diseases[J]. Eur J Clin Pharmacol，2019，75（11）：1547-1553.
李倩，朱坤，杨善鹏，等. 人血浆中羟氯喹高效液相色谱测定方法的建立及其应用[J]. 中国药师，2021，24（3）：587-591.
LI Q，ZHU K，YANG S P，et al. Establishment and application of a determination method for hydroxychloroquine in human plasma by HPLC[J]. China Pharm，2021，24（3）：587-591.
马莉. 羟氯喹在高原光线性皮肤病治疗中的疗效观察[J]. 青海医药杂志，2014，44（7）：32-33.
MA L. Observation of the therapeutic effect of hydroxychloroquine in the treatment of high-altitude photodermatitis[J] Qinghai Med J，2014，44（7）：32-33.
BOONPIYATHAD T，SANGASAPAVILIYA A. Hydroxychloroquine in the treatment of anti-histamine refractory chronic spontaneous urticaria，randomized single-blinded placebo-controlled trial and an open label comparison study[J]. Eur Ann Allergy Clin Immunol，2017，49（5）：220-224.
余恒毅，徐艳娇，向东，等. LC-MS/MS法同时测定拉考沙胺和吡仑帕奈的血浆药物浓度[J]. 中国药房，2023，34（16）：1979-1983.
YU H Y，XU Y J，XIANG D，et al. Simultaneous determination of lacosamide and perampanel concentration in human plasma by LC-MS/MS[J]. China Pharm，2023，34（16）：1979-1983.
国家药典委员会. 中华人民共和国药典：四部[M]. 2020年版. 北京：中国医药科技出版社，2020：466-472.
National Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China：part Ⅳ[M]. 2020 edition. Beijing：China Medical Technology Press，2020：466-472.
郑新，陈宇，刘伟武，等. 口服拉贝洛尔母乳药动学的风险评估与哺乳期合理用药[J]. 中国医院药学杂志，2018，38（19）：2013-2016.
ZHENG X，CHEN Y，LIU W W，et al. Risk assessment of the human milk pharmacokinetics and rational drug use during lactation by taking labetalol orally[J]. Chin J Hosp Pharm，2018，38（19）：2013-2016.
NATION R L，HACKETT L P，DUSCI L J，et al. Excretion of hydroxychloroquine in human milk[J]. Br J Clin Pharmacol，1984，17（3）：368-369.
史爱欣，李可欣，胡欣. HPLC-MS/MS法测定人血浆及尿液中贝他斯汀浓度及药动学研究[J]. 药物分析杂志，2014，34（12）：2139-2144.
SHI A X，LI K X，HU X. Study on determination of bepotastine in human plasma and urine by HPLC-MS/MS and pharmacokinetics[J]. Chin J Pharm Anal，2014，34（12）：2139-2144.
SHENTU J Z，ZHOU H L，HU X J，et al. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers：an open-label，rando- mized，single-dose，2-way crossover study[J]. Clin Ther，2014，36（4）：579-585.
INGLE R G，ZENG S，JIANG H D，et al. Current developments of bioanalytical sample preparation techniques in pharmaceuticals[J]. J Pharm Anal，2022，12（4）：517-529.
李宁红，赵婷慧，乔蕊，等. 乳汁中药物浓度测定的研究进展[J]. 中国医院药学杂志，2021，41（11）：1163-1170.
LI N H，ZHAO T H，QIAO R，et al. Determination of drug concentration in human milk[J]. Chin J Hosp Pharm，2021，41（11）：1163-1170.
CHOI Y K，CHUNG Y H，NAM Y S，et al. UPLC-MS/MS method for determination of bepotastine in human plasma[J]. J Chromatogr Sci，2014，52（8）：886-893.
刘容吉，张乐嘉，付强，等. 高效液相色谱法测定人乳汁中羟氯喹浓度[J]. 临床药物治疗杂志，2016，14（2）：23-26.
LIU R J，ZHANG L J，FU Q，et al. Determination of hydroxychloroquine in human breast milk by HPLC[J]. Clin Med J，2016，14（2）：23-26.
GAO B B，TAN T F，CAO X，et al. Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions[J]. BMC Med Genomics，2022，15（1）：23.
AUSTIN D，JOHN C，HUNT B J，et al. Validation of a li- quid chromatography tandem mass spectrometry method for the simultaneous determination of hydroxychloroquine and metabolites in human whole blood[J]. Clin Chem Lab Med，2020，58（12）：2047-2061.
0
Views
0
下载量
0
CSCD
- L-PDFDownload
- WORDDownload
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
- Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号
公网安备50010302001817 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.